
Friday 28 August
7:30 pm - 10:30 pm
River View Room 4
Beyond the Data: The Psychology of Decision-Making in IBD Care

Saturday 29 August
7:00 am - 8:20 am
Meeting Room 6
AGW Olympus Symposium
AI in Endoscopy: Hype, Help or Harm?
Chaired by: Matthew Remedios, Gastroenterologist, Theraputic Endoscopist and GESA Endoscopy Faculty Chair.
Overview:
AI is moving faster than evidence, policy and clinical behaviour. Are we improving outcomes - or accelerating complexity? This session isn’t designed to create agreement - it’s designed to challenge it. Expect strong opinions, uncomfortable questions, and spirited debate as experts examine the real-world implications of AI adoption in endoscopy.
Click here for more information.

Register via QR code below:

Saturday 29 August
7:00 am - 8:20 am
Meeting Room 8
AGW Takeda Symposium
Treating to Target in Ulcerative Colitis: From
Principle to Practice
Join your colleagues for an expert‑led breakfast symposium. As treatment
goals evolve beyond symptom control towards disease clearance, this
session will examine the clinical consequences of persistent inflammation
and the rationale for earlier use of advanced therapy. Presentations will
draw on real‑world cases and Australian experience to provide practical
guidance on when to escalate treatment.
Click here for more information.
Presenters:

Register via QR code below:

Sunday 30 August
7:00 am - 8:20 am
Meeting Room 6
AGW Novo Nordisk Symposium
Wegovy® (semaglutide): A new standard of care in
MASH management
Speakers:

Dr Nick Lan
Cardiologist in the Cardiometabolic service of
Fiona Stanley Hospital and Clinical Senior Lecturer at the University of
Western Australia. His expertise is in preventive cardiology and
cardiometabolic medicine, having undertaken a Clinical Fellowship in
Endocrinology and Diabetes and a Masters in Preventative Cardiovascular
Medicine. Nick is Co-Chair of the Cardiometabolic and Vascular Medicine Council
of the Australian Atherosclerosis Society and a Section Editor for the journal
Heart, Lung and Circulation. He has completed a Master of Clinical Research
with Distinction and was a recipient of the WA Health Research Fellowship. He
has published a book chapter on lipids in diabetes and >100 peer-reviewed
journal articles (>50 as first author). Nick's research is currently
supported by the WA Future Health Research and Innovation Fund.

A/Prof Marie Sinclair
and a transplant
hepatologist at Austin Health, Australia. Her research focuses on obesity,
MASLD, sarcopenia, and nutrition in advanced liver disease, with extensive
experience in multicentre clinical trials and translational hepatology
research.

Sunday 30 August
7:00 am - 8:20 am
Meeting Room 8
AGW Johnson & Johnson Symposium
Aim Higher. Expecting More. Tremfya in Crohn’s Disease
Join us at AGW 2026 for an engaging Breakfast Symposium, Aiming Higher.
Expecting More. TREMFYA in Crohn’s Disease, chaired by Prof Rupert Leong and featuring Prof Anita Afzali. This session will explore the pivotal GALAXI and GRAVITI data, highlight key endoscopic and deep remission outcomes, and examine how TREMFYA may be positioned within the evolving treatment landscape. Through subgroup insights and real-world US experience, we will translate evidence into practical clinical decision-making, including induction strategies and safety considerations.
Presenters:

